½ÃÀ庸°í¼­
»óǰÄÚµå
1489196

¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Fluorescence Guided Surgery Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 9,311¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 3¾ï 9,598¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2024-2032³â CAGRÀº 17.45%ÀÔ´Ï´Ù.

Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛÀº ü³»ÀÇ Æ¯Á¤ Ç¥Àû¿¡¼­ ¹æÃâµÇ´Â Çü±¤ ½ÅÈ£¸¦ °¨ÁöÇÏ¿© ¼ö¼ú Áß Á¶Á÷ÀÇ °¡½Ã¼ºÀ» Çâ»ó½ÃŰ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ÀϹÝÀûÀ¸·Î Á¾¾çÀ̳ª Áúº´ ¼¼Æ÷¿Í °°Àº Ç¥Àû Á¶Á÷¿¡ ¼±ÅÃÀûÀ¸·Î ÃàÀûµÇ´Â Çü±¤ Á¶¿µÁ¦¸¦ Åõ¿©ÇÕ´Ï´Ù. ±×·± ´ÙÀ½ ¿Ü°ú ÀÇ»ç´Â Ư¼ö ¿µ»ó Áø´Ü Àåºñ¸¦ »ç¿ëÇÏ¿© ÀÌ·¯ÇÑ Ç¥Àû Á¶Á÷À» ½Äº°Çϰí Á¤È®ÇÏ°Ô Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ¼ö¼ú °á°ú¸¦ °³¼±Çϰí ÁÖº¯ °Ç°­ÇÑ Á¶Á÷¿¡ ´ëÇÑ ¼Õ»óÀ» ÁÙÀ̸ç, º¸´Ù Á¤È®ÇÑ Á¾¾ç Á¦°Å¿Í Àå±â º¸Á¸À» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

Ç¥Àû Çü±¤ ¿°·á ¹× °íÇØ»óµµ À̹Ì¡ ½Ã½ºÅÛ °³¹ß µî Çü±¤ À̹Ì¡ ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ö¼ú Áß Á¶Á÷°ú Àå±âÀÇ Á¤È®ÇÑ ½Ã°¢È­°¡ °¡´ÉÇØÁ® ¼ö¼ú °á°ú¿Í ȯÀÚÀÇ ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃÖ¼Òħ½À ¼ö¼úÀÇ È®´ë¿Í ¾Ï, ½ÉÇ÷°ü Áúȯ°ú °°Àº º¹ÀâÇÑ ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ½Ç½Ã°£ ¼ö¼ú Áß ¾È³»¿Í Á¶Á÷ ºÐÈ­ °³¼±À» À§ÇÑ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å°æ¿Ü°ú, Á¾¾çÇÐ µî ÀüÅëÀûÀÎ ¿Ü°ú Àü¹® ºÐ¾ß»Ó¸¸ ¾Æ´Ï¶ó Á¤Çü¿Ü°ú, ºñ´¢±â°ú µîÀÇ ºÐ¾ß¿¡¼­µµ Çü±¤ À̹Ì¡ÀÇ Àû¿ëÀÌ È®´ëµÇ¸é¼­ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ÀáÀç·ÂÀÌ È®´ëµÇ°í ±â¼ú Çõ½ÅÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í »óȯ Á¤Ã¥Àº µµÀÔ À庮À» ³·Ãß°í ±¸¸Å¸¦ ¿ëÀÌÇÏ°Ô ÇÔÀ¸·Î½á ½ÃÀå ħÅõ¸¦ ÃËÁøÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ±â¼ú Çõ½Å°ú °æÀïÀûÀÎ ¼ö¼ú ¹æ¹ý·ÐÀº ÇâÈÄ ¼ö³â°£ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ¼ºÀå¿¡ µµÀüÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´ë»óÀ¸·Î Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ & ¾ÆÇÁ¸®Ä«¿¡¼­ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀåÀÇ ÇöÀç ¹× ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ç°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤¡¤¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

Ä¿½ºÅÒ ¿ä°ÇÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. Value Market ResearchÀÇ Á¶»çÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü ¸®Æ÷Æ®¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ - »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Çüº° ºÐ¼®
  • SPY ½Ã½ºÅÛ
  • PDE ½Ã½ºÅÛ
  • VS3 À̸®µã ½Ã½ºÅÛ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ¼ö¼úº°

  • ¼ö¼úº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¼ö¼úº° ºÐ¼®
  • °³º¹¼ö¼ú
  • º¹°­°æ/³»½Ã°æ ¼ö¼ú

Á¦7Àå ¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¿ëµµº° ºÐ¼®
  • ¾Ï¼ö¼ú
  • ½ÉÀåÇ÷°ü ¿Ü°ú
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹Ì ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ÆÇ¸Å ºÐ¼®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÎ¹®º°
    • ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ±â¾÷ÀÇ °æÀï ±¸µµ

  • Çü±¤ °¡ÀÌµå ¼ö¼ú ½Ã½ºÅÛ ½ÃÀå °æÀï
  • Á¦ÈÞ¡¤Çù·Â¡¤ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ßÇ¥
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Stryker Corporation
  • Olympus Corporation
  • Karl Storz Se & Co. KG
  • Medtronic Plc
  • Carl Zeiss Meditec AG
  • Danaher Corporation(Leica Microsystems)
  • Hamamatsu Photonics K.K.
  • Shimadzu Corporation
  • LI-COR Inc.
  • PerkinElmer Inc.
  • Getinge(Fluoptics)
  • OnLume Inc.
  • Irillic Pvt. Ltd.
  • Curadel LLC
KSA 24.06.12

The global demand for Fluorescence Guided Surgery Systems Market is presumed to reach the market size of nearly USD 395.98 Million by 2032 from USD 93.11 Million in 2023 with a CAGR of 17.45% under the study period 2024-2032.

Fluorescence-guided surgery systems are medical devices that enhance the visualization of tissues during surgical procedures by detecting fluorescent signals emitted from specific targets within the body. These systems typically involve administering fluorescent contrast agents that selectively accumulate in target tissues, such as tumors or diseased cells. Surgeons can then use specialized imaging equipment to identify and precisely remove these targeted tissues, improving surgical outcomes, reducing damage to surrounding healthy tissue, and facilitating more precise tumor removal or organ preservation.

MARKET DYNAMICS

Advancements in fluorescence imaging technology, including developing targeted fluorophores and high-resolution imaging systems, enable precise visualization of tissues and organs during surgical procedures, enhancing surgical outcomes and patient safety. Moreover, the growing adoption of minimally invasive surgical techniques and the increasing prevalence of complex diseases, such as cancer and cardiovascular disorders, drive the demand for fluorescence guided surgery systems that offer real-time intraoperative guidance and improved tissue differentiation. Additionally, expanding applications of fluorescence imaging beyond traditional surgical specialties, such as neurosurgery and oncology, into fields like orthopedics and urology broadens the market potential of fluorescence-guided surgery systems and stimulates innovation. Furthermore, supportive regulatory frameworks and reimbursement policies facilitate market penetration by reducing barriers to adoption and enhancing affordability. However, technological innovations or competing surgical methodologies may challenge the market growth of fluorescence-guided surgery systems in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Fluorescence Guided Surgery Systems. The growth and trends of Fluorescence Guided Surgery Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Fluorescence Guided Surgery Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • SPY System
  • PDE System
  • VS3 Iridium System
  • Other

By Surgery

  • Open Surgery
  • Laparoscopic/Endoscopic Surgery

By Application

  • Cancer Surgeries
  • Cardiovascular Surgeries
  • Other

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Fluorescence Guided Surgery Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Fluorescence Guided Surgery Systems market include Stryker Corporation, Olympus Corporation, Karl Storz Se & Co. KG, Medtronic Plc, Carl Zeiss Meditec AG, Danaher Corporation (Leica Microsystems), Hamamatsu Photonics K.K., Shimadzu Corporation, LI-COR Inc., PerkinElmer Inc., Getinge (Fluoptics), OnLume Inc., Irillic Pvt. Ltd., Curadel LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FLUORESCENCE GUIDED SURGERY SYSTEMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Surgery
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Type
  • 5.4. SPY System Historic and Forecast Sales By Regions
  • 5.5. PDE System Historic and Forecast Sales By Regions
  • 5.6. VS3 Iridium System Historic and Forecast Sales By Regions
  • 5.7. Other Historic and Forecast Sales By Regions

6. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS BY SURGERY

  • 6.1. Overview By Surgery
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Surgery
  • 6.4. Open Surgery Historic and Forecast Sales By Regions
  • 6.5. Laparoscopic/Endoscopic Surgery Historic and Forecast Sales By Regions

7. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cancer Surgeries Historic and Forecast Sales By Regions
  • 7.5. Cardiovascular Surgeries Historic and Forecast Sales By Regions
  • 7.6. Other Historic and Forecast Sales By Regions

8. GLOBAL FLUORESCENCE GUIDED SURGERY SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FLUORESCENCE GUIDED SURGERY SYSTEMS COMPANIES

  • 9.1. Fluorescence Guided Surgery Systems Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF FLUORESCENCE GUIDED SURGERY SYSTEMS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Stryker Corporation
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Olympus Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Karl Storz Se & Co. KG
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Medtronic Plc
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Carl Zeiss Meditec AG
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Danaher Corporation (Leica Microsystems)
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Hamamatsu Photonics K.K.
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Shimadzu Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. LI-COR Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. PerkinElmer Inc.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Getinge (Fluoptics)
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. OnLume Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Irillic Pvt. Ltd.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Curadel LLC
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦